Estimating the survival advantage based on telomere length and serum biomarkers of aging

BACKGROUND: This study aimed to establish a model that estimates the survival advantage at the molecular level based on telomere length and serum biomarkers of aging, to explore clinical significance. METHODS: The study consisted of 100 healthy subjects and 40 type 2 diabetes mellitus patients, 20–9...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yilin, Li, Shijun, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540222/
https://www.ncbi.nlm.nih.gov/pubmed/28764708
http://dx.doi.org/10.1186/s12967-017-1267-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540222/
https://www.ncbi.nlm.nih.gov/pubmed/28764708
http://dx.doi.org/10.1186/s12967-017-1267-8

Ejemplares similares